Neurocrine Biosciences Inc
NBIXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Neurocrine Biosciences Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ProShare Advisors LLC | 2026-03-31 | 8,514 | $1.12M | SEC filing |
| LOOMIS SAYLES & CO L P | 2026-03-31 | 165,735 | $21.8M | SEC filing |
| Machina Capital S.A.S. | 2026-03-31 | 2,960 | $390K | SEC filing |
| Krilogy Financial LLC | 2026-03-31 | 8,540 | $1.1M | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 1,389,539 | $183M | SEC filing |
| Virtu Financial LLC | 2026-03-31 | 9,570 | Not shown | SEC filing |
| ATWOOD & PALMER INC | 2026-03-31 | 5 | $659 | SEC filing |
| EVERGREEN CAPITAL MANAGEMENT LLC | 2026-03-31 | 2,207 | $291K | SEC filing |
| PICTON MAHONEY ASSET MANAGEMENT | 2026-03-31 | 9 | $1.19K | SEC filing |
| MML INVESTORS SERVICES, LLC | 2026-03-31 | 8,151 | $1.07M | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 3,893 | $513K | SEC filing |
| CSS LLC/IL | 2026-03-31 | 6,950 | $916K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 41,308 | $5.44M | SEC filing |
| VestGen Advisors, LLC | 2026-03-31 | 2,334 | $364K | SEC filing |
| PRIMECAP MANAGEMENT CO/CA/ | 2026-03-31 | 496,340 | $65.4M | SEC filing |
| Generali Investments, Management Co LLC | 2026-03-31 | 8,882 | $1.17M | SEC filing |
| Nuveen, LLC | 2026-03-31 | 443,052 | $58.4M | SEC filing |
| SEEDS INVESTOR LLC | 2026-03-31 | 2,464 | $322K | SEC filing |
| Aberdeen Group plc | 2026-03-31 | 17,300 | $2.28M | SEC filing |
| VIRTUS ADVISERS, LLC | 2026-03-31 | 2,584 | $340K | SEC filing |
- Each value is checked against Neurocrine Biosciences Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Neurocrine Biosciences Inc's share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Neurocrine Biosciences Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-19 · GORMAN KEVIN CHARLES: Larger than all 28 other insider sales of Common Stock on file. SEC filing
- 2026-01-16 · Gano Kyle: Larger than 27 of the 28 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | Lippoldt Darin · Chief Legal Officer | Common Stock | S — Open market or private sale | −1,690 | 170.81 | SEC filing |
| 2026-06-29 | Lippoldt Darin · Chief Legal Officer | Common Stock | S — Open market or private sale | −8,110 | 170.03 | SEC filing |
| 2026-06-26 | Lippoldt Darin · Chief Legal Officer | Common Stock | S — Open market or private sale | −200 | 169.57 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | S — Open market or private sale | −1,843 | 167.31 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | S — Open market or private sale | −2,549 | 164.44 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | S — Open market or private sale | −6,896 | 165.79 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | S — Open market or private sale | −7,883 | 163.81 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | S — Open market or private sale | −5,829 | 166.56 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-29 | Lippoldt Darin · Chief Legal Officer | Non-Qualified Stock Option | M — Exercise or conversion of derivative security | −8,110 | SEC filing |
| 2026-06-29 | Lippoldt Darin · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +1,690 | SEC filing |
| 2026-06-29 | Lippoldt Darin · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +8,110 | SEC filing |
| 2026-06-29 | Lippoldt Darin · Chief Legal Officer | Non-Qualified Stock Option | M — Exercise or conversion of derivative security | −1,690 | SEC filing |
| 2026-06-26 | Lippoldt Darin · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +200 | SEC filing |
| 2026-06-26 | Lippoldt Darin · Chief Legal Officer | Non-Qualified Stock Option | M — Exercise or conversion of derivative security | −200 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | M — Exercise or conversion of derivative security | +10,000 | SEC filing |
| 2026-06-05 | SHERWIN STEPHEN A · Director | Common Stock | M — Exercise or conversion of derivative security | +15,000 | SEC filing |
Showing 8 of 34 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.